HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tetsuhiko Asao Selected Research
Tetsuhiko Asao Research Topics
Disease
15
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 07/2014
12
Neoplasms (Cancer)
04/2024 - 01/2016
4
Lung Neoplasms (Lung Cancer)
04/2024 - 01/2021
4
Disease Progression
01/2024 - 03/2022
4
Thymoma (Thymic Carcinoma)
11/2023 - 01/2016
3
Pneumonia (Pneumonitis)
04/2024 - 01/2021
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2022 - 10/2015
2
Asthma (Bronchial Asthma)
01/2024 - 01/2020
2
Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 07/2014
1
Tuberous Sclerosis (Bourneville's Disease)
04/2024
1
Carcinogenesis
04/2024
1
Lymphangioleiomyomatosis (Lymphangiomyomatosis)
04/2024
1
Cachexia
02/2023
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2023
1
Carcinoma (Carcinomatosis)
04/2022
1
Organizing Pneumonia
11/2021
1
Adenocarcinoma of Lung
11/2021
1
Anaphylaxis (Anaphylactic Shock)
01/2020
1
Stomach Neoplasms (Stomach Cancer)
01/2018
1
Lymphangiomyoma
01/2017
1
Febrile Neutropenia
10/2015
Drug/Important Bio-Agent (IBA)
6
Immune Checkpoint Inhibitors
IBA
03/2024 - 03/2016
5
pembrolizumab
IBA
01/2023 - 01/2021
4
Tyrosine Kinase Inhibitors
IBA
04/2024 - 03/2016
3
osimertinib
IBA
04/2024 - 01/2020
3
ErbB Receptors (EGF Receptor)
IBA
04/2024 - 01/2019
3
Platinum
IBA
01/2024 - 01/2021
3
Carboplatin (JM8)
FDA Link
Generic
11/2023 - 04/2022
3
Biomarkers (Surrogate Marker)
IBA
02/2023 - 01/2018
3
Pemetrexed (MTA)
FDA Link
01/2023 - 07/2014
2
durvalumab
IBA
01/2024 - 11/2022
2
Cisplatin (Platino)
FDA Link
Generic
01/2024 - 01/2017
2
Paclitaxel (Taxol)
FDA Link
Generic
11/2023 - 04/2022
2
Proteins (Proteins, Gene)
FDA Link
01/2023 - 01/2017
2
Etoposide (VP 16)
FDA Link
Generic
11/2022 - 01/2017
2
B7-H1 Antigen
IBA
11/2021 - 01/2021
2
Anaplastic Lymphoma Kinase
IBA
01/2019 - 01/2017
2
amrubicin
IBA
01/2017 - 10/2015
1
lipoarabinomannan (LAM)
IBA
04/2024
1
atezolizumab
IBA
11/2023
1
Chemokine CCL11
IBA
02/2023
1
Cytokines
IBA
02/2023
1
Bevacizumab (Avastin)
FDA Link
04/2022
1
Steroids
IBA
11/2021
1
Prednisolone (Predate)
FDA Link
Generic
11/2021
1
Gefitinib (Iressa)
FDA Link
01/2021
1
Zinc Finger E-box-Binding Homeobox 1
IBA
01/2021
1
Programmed Cell Death 1 Receptor
IBA
01/2021
1
mepolizumab
IBA
01/2020
1
Humanized Monoclonal Antibodies
IBA
01/2020
1
Insulin (Novolin)
FDA Link
01/2020
1
dupilumab
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
benralizumab
IBA
01/2020
1
Omalizumab (Xolair)
FDA Link
01/2020
1
Carrier Proteins (Binding Protein)
IBA
01/2018
1
NK Cell Lectin-Like Receptor Subfamily K
IBA
01/2018
1
alectinib
IBA
01/2017
1
ceritinib
IBA
01/2017
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2017
1
Sirolimus (Rapamycin)
FDA Link
01/2017
1
polysaccharide-K
IBA
01/2017
1
Investigational Drugs
IBA
03/2016
1
Cytotoxins (Cytolysins)
IBA
03/2016
1
Ligands
IBA
01/2016
Therapy/Procedure
10
Therapeutics
04/2024 - 01/2017
10
Drug Therapy (Chemotherapy)
03/2024 - 01/2016
3
Immunotherapy
03/2024 - 01/2018
2
Radiotherapy
01/2024 - 11/2017
2
Chemoradiotherapy
01/2024 - 11/2017
2
Bronchial Thermoplasty
01/2024 - 01/2020
1
Combination Drug Therapy (Combination Chemotherapy)
03/2024
1
Aftercare (After-Treatment)
01/2020
1
Gastrectomy
01/2018